Combined Treatment With TNF Inhibitor and Pamidronate in AS Patients: Effect on the Radiographic Progression

PHASE4UnknownINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

June 30, 2017

Study Completion Date

September 30, 2017

Conditions
Ankylosing Spondylitis
Interventions
DRUG

Pamidronate

intravenous infusion of pamidronate 60 mg

OTHER

Placebo (NaCl 0.9%)

intravenous infusion of NaCl 0.9% 500 ml

Trial Locations (1)

38041

Bnai Zion Medical Center, Haifa

Sponsors
All Listed Sponsors
collaborator

Janssen-Cilag Ltd.

INDUSTRY

lead

Bnai Zion Medical Center

OTHER_GOV